Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|May 5, 2026
Protein phosphatase 2A regulates senescence and immunogenicity in medulloblastoma modelsWinson S Ho, Isha Mondal, Jingjing Liu, et al.Elife|January 29, 2026
Mitochondrial protein carboxyl-terminal alanine-threonine tailing promotes human glioblastoma growth by regulating mitochondrial functionBei Zhang, Ting Cai, Esha Reddy, et al.Cancer Letters|December 5, 2017
LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiationWinson S Ho, Saman Sizdahkhani, Shuyu Hao, et al.Oncotarget|January 23, 2016
PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cellsWinson S Ho, Michael J Feldman, Dragan Maric, et al.The Journal of Clinical Investigation|February 9, 2023
PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophagesWinson S Ho, Isha Mondal, Beisi Xu, et al.Journal for Immunotherapy of Cancer|January 17, 2025
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) reviewAlessandra Cesano, Ryan Augustin, Luigi Barrea, et al.Nature Neuroscience|October 3, 2025
Brain tumors induce widespread disruption of calvarial bone and alteration of skull marrow immune landscapeAbhishek Dubey, Erika Yamashita, Biljana Stangeland, et al.Journal for Immunotherapy of Cancer|May 23, 2019
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.Journal for Immunotherapy of Cancer|July 6, 2019
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.Pageof 3